|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1156 15TH STREET, NW, #700 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 26422-24
|
||||||||
|
6. House ID# 302590000
|
||||||||
| TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Nicole McFarland |
Date | 7/19/2018 10:09:28 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
Reproductive Rights;
Religious Refusals;
International access to abortion and family planning;
Supreme Court ruling in National Institute of Family and Life Advocates (NIFLA) v. Becerra, regarding Californias Reproductive FACT Act and fake womens health centers;
The Trump administrations domestic gag rule, targeting Title X providers;
H.R.2566, Stop Deceptive Advertising for Womens Healthcare Services Act;
Sen. Booker letter regarding the Teen Pregnancy Prevention Program and adolescent sexual and reproductive health education.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
McGorman |
|
|
|
Kate |
Ryan |
|
|
|
Nicole |
McFarland |
|
|
|
Stephanie |
Yost |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Federal courts and judicial nominees, regarding reproductive rights;
U.S. Supreme Court Vacancy (Retirement of Associate Justice Anthony Kennedy);
Nomination of Michael Brennan to the Seventh Circuit Court of Appeals;
Nomination of Kurt Engelhardt to the Fifth Circuit Court of Appeals;
Nomination of Kyle Duncan to the Fifth Circuit Court of Appeals;
Nomination of David Porter to the Third Circuit Court of Appeals;
Nomination of Britt Grant to the Eleventh Circuit Court of Appeals;
Nomination of Ryan Bounds to the Ninth Circuit Court of Appeals;
Nomination of Andrew Oldham to the Fifth Circuit Court of Appeals;
Nomination of J. Campbell Barker to the U.S. District Court for the Eastern District of Texas;
Nomination of Andrew Brasher to the U.S. District Court for the Middle District of Alabama;
Nomination of Holly Brady to the U.S. District Court for the Northern District of Alabama;
Nomination of Patrick Wyrick to the U.S. District Court for the Western District of Oklahoma;
Nomination of Wendy Vitter to the U.S. District Court for the Eastern District of Louisiana;
Nomination of Allen Winsor to the U.S. District Court for the Northern District of Florida;
Nomination of Michael Truncale to the U.S. District Court for the Eastern District of Texas;
Nomination of Mike Pompeo to be secretary of the U.S. Department of State.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kate |
Ryan |
|
|
|
Leslie |
McGorman |
|
|
|
Nicole |
McFarland |
|
|
|
Stephanie |
Yost |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY19 Labor, Health and Human Services, and Education appropriations bill, regarding the Title X family planning program, funding for Planned Parenthood, religious refusal provisions, sex education, fetal-tissue research, and insurance coverage of abortion;
FY19 State and Foreign Operations and Related Programs appropriations bill, regarding international family planning, the United Nations Population Fund, reproductive rights in the State Departments Human Rights Report, and the global gag rule;
FY19 Financial Services and General Government appropriations Bill, regarding the D.C. abortion ban, D.C.s Reproductive Health Non-Discrimination Act, insurance coverage of abortion, and abortion coverage in the Federal Employees Health Benefits Program;
FY19 National Defense Authorization Act, regarding family planning and insurance coverage of abortion;
Schakowsky/Gallego Letter regarding poison-pill riders in FY19 appropriations bills.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
McGorman |
|
|
|
Kate |
Ryan |
|
|
|
Nicole |
McFarland |
|
|
|
Stephanie |
Yost |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |